5-epi-Torrubiellutin C shows antiproliferative activity on DU145 prostate cancer cells through inactivation of the AKT/mTOR pathway

Ashita Singh, Bodugam Mahipal, Srivari Chandrasekhar, Ramesh Ummanni
  • Anti-Cancer Drugs, April 2014, Wolters Kluwer Health
  • DOI: 10.1097/cad.0000000000000064

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Dr Srivari chandrasekhar